ID: ALA214837

Max Phase: Preclinical

Molecular Formula: C23H25N3O3S

Molecular Weight: 423.54

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(CCCCCSc1nc(O)cc(C(c2ccccc2)c2ccccc2)n1)NO

Standard InChI:  InChI=1S/C23H25N3O3S/c27-20(26-29)14-8-3-9-15-30-23-24-19(16-21(28)25-23)22(17-10-4-1-5-11-17)18-12-6-2-7-13-18/h1-2,4-7,10-13,16,22,29H,3,8-9,14-15H2,(H,26,27)(H,24,25,28)

Standard InChI Key:  ZMIRRXWAPLJEMZ-UHFFFAOYSA-N

Associated Targets(Human)

U-937 7138 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Histone deacetylase HD2 351 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Histone deacetylase HD1B 86 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 423.54Molecular Weight (Monoisotopic): 423.1617AlogP: 4.52#Rotatable Bonds: 10
Polar Surface Area: 95.34Molecular Species: NEUTRALHBA: 6HBD: 3
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 8.91CX Basic pKa: 1.43CX LogP: 5.27CX LogD: 5.26
Aromatic Rings: 3Heavy Atoms: 30QED Weighted: 0.15Np Likeness Score: -0.73

References

1. Mai A, Massa S, Rotili D, Simeoni S, Ragno R, Botta G, Nebbioso A, Miceli M, Altucci L, Brosch G..  (2006)  Synthesis and biological properties of novel, uracil-containing histone deacetylase inhibitors.,  49  (20): [PMID:17004718] [10.1021/jm0605536]

Source